AzTrials
AzTrials

Return to WorkVital@WorkNCT06543732

Vital@Work: Reintegration Program for Employees with Stress-related Complaints

A study testing Return to work program in people with Return to Work and Mental Health, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 4 sites in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study, Vital@Work reintegration program, is to support sick-listed workers with stress-related complaints in their return to work based on a personalized program. Read more about this study

Who is it for?
Ages 18 to 68 yearsHealthy volunteers can take part
Conditions the study is for
Return to Work, Mental Health
What is being tested?
Return to work program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
208 participants
Where
4 sitesNetherlands
Study dates
8 Jan 2025to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 68 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Sick-listed employees from participating organisations (Amsterdam UMC, GGZ inGeest, Rijksschoonmaakorganisatie [RSO], and Transavia)
  • Aged 18-68
  • Between 2 and 12 weeks on sick leave
  • Suffering from stress-related complaints

Who cannot join

  • Non-sick-listed employees
  • Suffering from severe psychiatric disorders (e.g., suicidality, mania, psychosis, schizophrenia) or other chronic conditions (e.g., terminal illness) that could significantly affect the employee's mental health and, hence, prevent the return-to work process
  • Being pregnant or less than three months after delivery
  • Sick-listed for more than 12 weeks
  • Inability to complete either the eHealth modules or questionnaires
  • Presence of a legal conflict with the employer
  • Not signing informed consent

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Trees Juurlink, PhD contact

+31613731701

t.juurlink@amsterdamumc.nl

Netherlands4 sites, 4 recruiting
  • Amsterdam UMC

    Amsterdam

    Robbert de Leeuw

    Recruiting
  • GGZ inGeest

    Amsterdam

    Stephanie Mees ten Oever

    Recruiting
  • Transavia

    Amsterdam

    Bonny de Vries

    Recruiting
  • RSO

    The Hague

    Fred Verhees

    Recruiting

Other trials in Netherlands

About this study

Official title: Vital@Work: a Personalized Reintegration Program for Employees with Stress-related Complaints

The objective of this study, Vital@Work reintegration program, is to support sick-listed workers with stress-related complaints in their return to work based on a personalized program. Therefore, the aim of this study is test whether participants supported by a tailored eHealth program, and if needed, additionally supported by a structured and stepwise Participatory Approach (PA) involving the sick-listed worker, their direct supervisor and a neutral party, show a faster and sustainable return to work as compared to participants in the control condition. This program is investigated in four different organizations, which differ in sector, size (small and large organizations), type of organization (private or public) and type of work.

Read the detailed description

This study evaluates the effectiveness of a program, incorporating diverse components, to improve sustainable return to work, stress-related outcomes and cost effectiveness among sick-listed workers with stress-related complaints compared to usual care. The study design is a randomized controlled trial, including an intervention and control group. Sick-listed workers between 2 - 12 weeks sick, in the intervention group receive a tailored eHealth program based on their questions on a distress screener, if needed followed by the Participatory Approach (PA). Sick-listed workers in the control group receive standard practice and general information about return to work. If sick-listed workers did not return to work after 6 weeks in the eHealth program, the PA starts. The PA is a structured and stepwise procedure that involves the sick-listed worker, their direct supervisor, and a neutral party (either physically present or working in the background) to guide the conversation. This collaborative process aims to identify workplace-related bottlenecks, and subsequently develop a consensus-based return to work plan based on a strong commitment of both the sick listed worker and employer. This study offers two different forms of PA: individual work modifications (guided by a neutral process facilitator) and job coaching (guided by the employer, with the process facilitator providing support in the background). If sick-listed workers are experiencing stress-related complaints originating from work, they will be offered individual work modifications. Conversely, if the issues are unrelated to work, the worker will receive job coaching. As information on this tailored PA approach is lacking, the effectiveness of this approach is investigated. By combining these different intervention components, the investigators strive to fill the research gap concerning the identification of an effective re-integration program for sick-listed workers suffering from stress-related complaints. Participants will be followed for 1 year.

Being tested
Return to work program
Keywords
Return to work, Stress, Absenteeism
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Return to work programOther

    The eHealth modules focus on psychoeducation, perceptions of return to work based on a personal plan including problem-solving exercises, relapse prevention, and continuous monitoring. If needed, followed by the participatory approach, a stepwise, collaborative approach to analyse and solve bottlenecks to develop a consensus-based plan for return to work.

Study groups in NCT06543732
Study groupRoleWhat they receive
eHealth with Participatory Approach if neededExperimentalParticipants receive a personalized eHealth program and if needed, after 6 weeks the Participatory Approach (intervention) next to care as usual from occupational health care.
Receives: Other: Return to work program
Control conditionNo interventionParticipants receive links to existing websites on return to work next to care as usual from occupational health care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lasting return to work

    Lasting return to work of at least 28 consecutive days without (partial or full) relapse

    Measured: Baseline - 3 months - 6 months -12 months

Secondary outcomes (3)
  1. Stress-related complaints

    Stress-related complaints (e.g., type of disease, severity of symptoms) by means of the 4DKL (Terluin, 2008), Promis (Terwee et al. 2015).

    Measured: Baseline - 3 months - 6 months -12 months

  2. Psychosocial job characteristics

    Psychosocial job characteristics (e.g., mental workload, decision latitude, social support, physical demands, job insecurity) by means of the JCQ (Karasek, Houtman et al. 1995)

    Measured: Baseline - 3 months - 6 months - 12 months

  3. Behaviour change

    Behaviour change (e.g., attitude, social influence, self-efficacy); by means of the ASE (Damoiseaux et al. 1998), RTW-SE (Volker et al. 2015).

    Measured: Baseline - 3 months - 6 months - 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2024
  2. Study start8 Jan 2025
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial comparing intervention group with care as usual group. Randomization is carried out at the individual level stratified by organisation type and whether problems are perceived as work-related or not.
Masking
Single blind
Who is masked
Participant
Enrolment
208 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06543732
Sponsor's protocol ID
2024.0021
Acronym
Vital@Work
Status last verified
Jan 2025
First submitted
5 Aug 2024
Last updated
30 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • van Doeveren EEM, de Smalen AW, Schelvis RMC, Beekman ATF, Anema JR, Juurlink TT. Vital@Work reintegration programme for sick-listed workers with stress-related complaints in occupational healthcare in the Netherlands: study protocol of a randomised controlled trial. BMJ Open. 2026 Sep 30;16(9):e116576. doi: 10.1136/bmjopen-2026-116576.

    PubMed 42816073

Questions about this trial

What is this clinical trial studying?

A study testing Return to work program in people with Return to Work and Mental Health, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) at 4 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Trees Juurlink, PhD (+31613731701, t.juurlink@amsterdamumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lasting return to work (time frame: Baseline - 3 months - 6 months -12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06543732, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in